Igor Moroz, Pharmasyntez Chief Executive Officer, reported on existing manufacture and made a point that the plant in Irkutsk was not only the largest manufacturing site of the group of companies, but also a high-capacity research center.

The guests visited with excursions manufacture shop No5 and physical-chemical laboratory of quality control department.

“It is very important now to support domestic pharmaceutical industry, to help our companies, such as Pharmasyntez, in developing, increasing production volumes, and reducing dependence on imported drugs”, Aleksandr Vedernikov pointed out.